由寄生人体的蠕虫感染所致的疾病称为蠕虫病。这些蠕虫主要包括绦虫、线虫和吸虫。据世界卫生组织(WHO)估计,全球约有近20亿人口受到蠕虫感染的影响,这严重威胁着人类的健康和社会经济的发展。
近年来,开发出了许多广谱、高效且安全的抗蠕虫药物,例如阿苯达唑和甲苯达唑,这些新药已经取代了传统的山道年和己雷琐辛等。吡喹酮对血吸虫病的治愈率可达90%以上,而乙胺嗪则是治疗丝虫病的有效药物。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
阿苯达唑亚砜 | 4-(methylsulfonylamino)phenol | 51767-39-6 | C7H9NO3S |
|
阿苯达唑亚砜 | ricobendazole | 54029-12-8 | C12H15N3O3S |
|
芬苯达唑 | fenbendazole | 43210-67-9 | C15H13N3O2S |
|
氢溴酸槟榔碱 | arecoline hydrobromide | 300-08-3 | BrH*C8H13NO2 |
|
安丝菌素 P 3 | ansamitocin P-3 | 66584-72-3 | C32H43ClN2O9 |
|
多拉菌素 | doramectin | 117704-25-3 | C50H74O14 |
|
—— | Dectomax | 117704-25-3 | C50H74O14 |
|
—— | (1'R,2R,3S,4'S,6S,8'R,10'E,13'S,14'E,16'E,20'R,21'R,24'S)-2-cyclohexyl-21',24'-dihydroxy-12'-[(2R,4S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-3,11',13',22'-tetramethylspiro[2,3-dihydropyran-6,6'-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene]-2'-one | 117704-25-3 | C50H74O14 |
|
—— | Pharmakon1600-01505902 | 117704-25-3 | C50H74O14 |
|
—— | (1'R,2R,3S,4'S,6S,8'R,12'S,13'S,20'R,21'R,24'S)-2-cyclohexyl-21',24'-dihydroxy-12'-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-3,11',13',22'-tetramethylspiro[2,3-dihydropyran-6,6'-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene]-2'-one | 117704-25-3 | C50H74O14 |
|
—— | (1'R,2R,3S,4'S,6S,8'R,10'E,12'S,13'S,14'E,16'E,20'R,21'R,24'S)-2-cyclohexyl-21',24'-dihydroxy-12'-[(2R,4S,5S,6S)-5-[(2S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-3,11',13',22'-tetramethylspiro[2,3-dihydropyran-6,6'-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene]-2'-one | 117704-25-3 | C50H74O14 |
|
—— | 3-O-De[2-(acetylmethylamino)-1-oxopropyl]-3-O-(1-oxobutyl)maytansine | 66584-72-3 | C32H43ClN2O9 |
|
—— | Doramectin synthetic | 117704-25-3 | C50H74O14 |
|
—— | Maytansine, 2'-de(acetylmethylamino)-2'-methyl- | 66584-72-3 | C32H43ClN2O9 |
|
—— | (1'R,2R,3S,4'S,6S,8'R,10'Z,12'S,14'Z,16'Z,20'R,21'R,24'S)-2-cyclohexyl-21',24'-dihydroxy-12'-[(2R,4S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-3,11',13',22'-tetramethylspiro[2,3-dihydropyran-6,6'-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene]-2'-one | 117704-25-3 | C50H74O14 |
|
—— | ansamitocin P-3 | 66584-72-3 | C32H43ClN2O9 |
|
—— | Epi-doramectin | 117704-25-3 | C50H74O14 |
|
—— | Ansamitocin P 3 | 66584-72-3 | C32H43ClN2O9 |
|